Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials

Particle and Fibre Toxicology

Volumn 11, Issue 1, 2014, Pages

  Landsiedel, Robert ^a   Ma Hock, Lan ^a   Hofmann, Thomas ^a   Wiemann, Martin ^b   Strauss, Volker ^a   Treumann, Silke ^a   Wohlleben, Wendel ^a   Gröters, Sibylle ^a   Wiench, Karin ^a   Van Ravenzwaay, Bennard ^a  

^a BASF SE   (Germany)

^b Institute for Biological Emission Evaluation   (Germany)

Author keywords

BaSO4; Bronchoalveolar lavage; CeO2; Cytokine chemokine; Inhalation; Nanomaterial; Rat; Respiratory tract histopathology; SiO2; TiO2; ZnO; ZrO2

Indexed keywords

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; APOPTOSIS; BARIUM SULFATE; BODY BURDEN; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROLIFERATION; CERIUM; COATED MATERIALS, BIOCOMPATIBLE; LUNG; MALE; MICROSCOPY, ELECTRON, SCANNING; NANOSTRUCTURES; OXIDES; RATS; RATS, WISTAR; SILICON DIOXIDE; TITANIUM; WEIGHT GAIN; ZINC OXIDE; ZIRCONIUM;

EID: 84899482733     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-11-16     Document Type: Article

References (73)

1. Ma-Hock L, Burkhardt S, Strauss V, Gamer AO, Wiench K, van Ravenzwaay B, Landsiedel R. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal Toxicol 2009, 21:102-118. 10.1080/08958370802361057, 18800274.
2. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 2004, 77:347-357. 10.1093/toxsci/kfh019, 14600271.
3. Klein CL, Wiench K, Wiemann M, Ma-Hock L, van Ravenzwaay B, Landsiedel R. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol 2012, 86:1137-1151. 10.1007/s00204-012-0834-2, 22532024.
4. Donaldson K, Brown D, Clouter A, Duffin R, Macnee W, Renwick L, Tran L, Stone V. The pulmonary toxicology of ultrafine particles. J Aerosol Med 2002, 15:213-220. 10.1089/089426802320282338, 12184871.
5. Monteiller C, Tran L, Macnee W, Faux S, Jones A, Miller B, Donaldson K. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 2007, 64:609-615. 10.1136/oem.2005.024802, 2092561, 17409182.
6. Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 1992, 97:193-199. 1519541, 1396458.
7. Bermudez E, Mangum JB, Asgharian B, Wong BA, Reverdy EE, Janszen DB, Hext PM, Warheit DB, Everitt JI. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of micron-scale titanium dioxide particles. Toxicol Sci 2002, 70:86-97. 10.1093/toxsci/70.1.86, 12388838.
8. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007, 97:163-180. 10.1093/toxsci/kfm018, 17301066.
9. Cho WS, Duffin R, Poland CA, Howie SE, Macnee W, Bradley M, Megson IL, Donaldson K. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 2010, 118:1699-1706. 10.1289/ehp.1002201, 3002189, 20729176.
10. Merget R, Bauer T, Kupper HU, Philippou S, Bauer HD, Breitstadt R, Bruening T. Health hazards due to the inhalation of amorphous silica. Arch Toxicol 2002, 75:625-634. 10.1007/s002040100266, 11876495.
11. Johnston CJ, Driscoll KE, Finkelstein JN, Baggs R, O'Reilly MA, Carter J, Gelein R, Oberdörster G. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol Sci 2000, 56:405-413. 10.1093/toxsci/56.2.405, 10911000.
12. Arts JH, Muijser H, Duistermaat E, Junker K, Kuper CF. Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. Food Chem Toxicol 2007, 45:1856-1867. 10.1016/j.fct.2007.04.001, 17524541.
13. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 2000, 12:1113-1126. 10.1080/08958370050166796, 11114784.
14. Pott F, Roller M. Carcinogenicity study with nineteen granular dusts in rats. Eur J Oncol 2005, 10:249-281.
15. Srinivas A, Rao PJ, Selvam G, Murthy PB, Reddy PN. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett 2011, 205:105-115. 10.1016/j.toxlet.2011.05.1027, 21624445.
16. Ma JY, Zhao H, Mercer RR, Barger M, Rao M, Meighan T, Schwegler-Berry D, Castranova V, Ma JK. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicol 2011, 5:312-325.
17. Toya T, Takata A, Otaki N, Takaya M, Serita F, Yoshida K, Kohyama N. Pulmonary toxicity induced by intratracheal instillation of coarse and fine particles of cerium dioxide in male rats. Ind Health 2010, 48:3-11. 10.2486/indhealth.48.3, 20160402.
18. McDonald JW, Ghio AJ, Sheehan CE, Bernhardt PF, Roggli VL. Rare earth (cerium oxide) pneumoconiosis: analytical scanning electron microscopy and literature review. Mod Pathol 1995, 8:859-865.
19. Valberg PA, Bruch J, McCunney RJ. Are rat results from intratracheal instillation of 19 granular dusts a reliable basis for predicting cancer risk?. Regul Toxicol Pharmacol 2009, 54:72-83. 10.1016/j.yrtph.2009.02.008, 19275925.
20. Hartwig A. Gesundheitsschädliche Arbeitsstoffe. Toxikologisch-arbeitsmedizinische Begründung von MAK-Werten 2013, Weinheim: VCH Verlagsgesellschaft.
21. German Federal Ministry of Labour and Social Affairs (BMAS; Bundesministerium für Arbeit und Soziales) Bekanntmachung von technischen Regeln. (Notice of technical provisions). TRGS 900 Arbeitsplatzgrenzwerte (Workplace limits) 2014, Notice IIIb 3 - 35125 - 5 of the BMAS, German Federal Ministry of Labour and Social Affairs (BMAS; Bundesministerium für Arbeit und Soziales).
22. Wohlleben W, Ma-Hock L, Boyko V, Cox G, Egenolf H, Freiberger H, Hinrichsen B, Hirth S, Landsiedel R. Nanospecific guidance in REACH: a comparative physicalchemical characterization of 15 materials with methodical correlations. J Ceramic Sci Technol 2013, 4:93-104.
23. Hellack B, Hülser T, Izak E, Kuhlbusch T, Meyer F, Spree M, Voetz M, Wiggers H, Wohlleben W. Characterization report for all nanoGEM materials 2009, Frankfurt: Dechema eV.
24. Sauer UG, Vogel S, Aumann A, Hess A, Kolle SN, Ma-Hock L, Wohlleben W, Dammann M, Strauss V, Treumann S, Groters S, Wiench K, van Ravenzwaay B, Landsiedel R. Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. Toxicol Appl Pharmacol 2013, epub ahead of print.
25. Kuhlbusch THJ, Krug HF, Nau K. Nanocare - Health related effects of nanoparticles. Final scientific report 2009, Frankfurt: Dechema eV.
26. Cullen RT, Tran CL, Buchanan D, Davis JM, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol 2000, 12:1089-1111. 10.1080/08958370050166787, 11114783.
27. van Ravenzwaay B, Landsiedel R, Fabian E, Burkhardt S, Strauss V, Ma-Hock L. Comparing fate and effects of three particles of different surface properties: nano-TiO2, micron-scale TiO2 and quartz. Toxicol Lett 2009, 186:152-159. 10.1016/j.toxlet.2008.11.020, 19114093.
28. Hadjimichael OC, Brubaker RE. Evaluation of an occupational respiratory exposure to a zirconium-containing dust. J Occup Med 1981, 23:543-547.
29. Marcus RL, Turner S, Cherry NM. A study of lung function and chest radiographs in men exposed to zirconium compounds. Occup Med (Lond) 1996, 46:109-113. 10.1093/occmed/46.2.109, 8776246.
30. Anjilvel S, Asgharian B. A multiple-path model of particle deposition in the rat lung. Fundam Appl Toxicol 1995, 28:41-50. 10.1006/faat.1995.1144, 8566482.
31. RIVM (Netherlands National Institute for Public Health and the Environment) Multiple Path Particle Dosimetry Model (MPPD v 1.0): A Model for Human and Rat Airway Particle Dosimetry 2002, Bilthoven, The Netherlands: RIVA Report 650010030, RIVM (Netherlands National Institute for Public Health and the Environment).
32. Warheit DB, Hartsky MA. Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species. Microsc Res Tech 1993, 26:412-422. 10.1002/jemt.1070260509, 8286787.
33. Zhou J, Xu N, Wang ZL. Dissolving behavior and stability of ZnO wires in biofluids: a study on biodegradability and biocompatibility of ZnO nanostructures. Adv Mater 2006, 18:2432-2435.
34. Ma-Hock L, Treumann S, Strauss V, Brill S, Luizi F, Mertler M, Wiench K, Gamer AO, van Ravenzwaay B, Landsiedel R. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol Sci 2009, 112:468-481. 10.1093/toxsci/kfp146, 19584127.
35. Ma-Hock L, Strauss V, Treumann S, Küttler K, Wohlleben W, Hofmann T, Gröters S, Wiench K, van Ravenzwaay B, Landsiedel R. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol 2013, 10:23. 10.1186/1743-8977-10-23, 3720229, 23773277.
36. Ma-Hock L, Brill S, Wohlleben W, Farias PMA, Chaves CR, Tenório DPLA, Fontes A, Santos BS, Landsiedel R, Strauss V, Treumann S, van Ravenzwaay B. Short term inhalation toxicity of a liquid aerosol of CdS/Cd(OH)2 core shell quantum dots in male Wistar rats. Toxicol Lett 2012, 208:115-124. 10.1016/j.toxlet.2011.10.011, 22027348.
37. Ma-Hock L, Farias PMA, Hofmann T, Andrade ACDS, Silva JN, Arnaud TMS, Wohlleben W, Strauss V, Treumann S, Chaves CRS, Gröters S, Landsiedel R, van Ravenzwaay B. Short term inhalation toxicity of a liquid aerosol of glutaraldehyde-coated CdS/Cd(OH)2 core shell quantum dots in rats. Toxicol Lett 2014, 225:20-26. 10.1016/j.toxlet.2013.11.007, 24296008.
38. Ma-Hock L, Landsiedel R, Wiench K, Geiger D, Strauss V, Gröters S, van Ravenzwaay B, Gerst M, Wohlleben W, Scherer G. Short-term rat inhalation study with aerosols of acrylic ester-based polymer dispersions containing a fraction of nanoparticles. Int J Toxicol 2012, 31:46-57. 10.1177/1091581811424778, 22267870.
39. Maus U, Herold S, Muth H, Maus R, Ermert L, Ermert M, Weissmann N, Rosseau S, Seeger W, Grimminger F, Lohmeyer J. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol 2001, 280:L58-L68.
40. Donaldson K, Borm PJ, Oberdörster G, Pinkerton KE, Stone V, Tran CL. Concordance between in vitro and in vivo dosimetry in the proinflammatory effects of low-toxicity, low-solubility particles: the key role of the proximal alveolar region. Inhal Toxicol 2008, 20:53-62. 10.1080/08958370701758742, 18236223.
41. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology 1997, Philadelphia, USA: W.B. Saunders Company.
42. Matsunaga I, Oka S, Fujiwara N, Yano I. Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycoloyl glycolipids from Rhodococcus ruber (Nocardia rubra). J Biochem 1996, 120:663-670. 10.1093/oxfordjournals.jbchem.a021463, 8902634.
43. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993, 7:1475-1482.
44. Scott JA, Weir ML, Wilson SM, Xuan JW, Chambers AF, McCormack DG. Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. Am J Physiol 1998, 275:H2258-H2265.
45. Chiba S, Rashid MM, Okamoto H, Shiraiwa H, Kon S, Maeda M, Murakami M, Inobe M, Kitabatake A, Chambers AF, Uede T. The role of osteopontin in the development of granulomatous lesions in lung. Microbiol Immunol 2000, 44:319-332. 10.1111/j.1348-0421.2000.tb02501.x, 10832978.
46. O'Regan AW, Hayden JM, Body S, Liaw L, Mulligan N, Goetschkes M, Berman JS. Abnormal pulmonary granuloma formation in osteopontin-deficient mice. Am J Respir Crit Care Med 2001, 164:2243-2247. 10.1164/ajrccm.164.12.2104139, 11751194.
47. Mangum J, Bermudez E, Sar M, Everitt J. Osteopontin expression in particle-induced lung disease. Exp Lung Res 2004, 30:585-598. 10.1080/01902140490476346, 15371094.
48. Driscoll KE, Hassenbein DG, Carter JM, Kunkel SL, Quinlan TR, Mossman BT. TNF alpha and increased chemokine expression in rat lung after particle exposure. Toxicol Lett 1995, 82-83:483-489.
49. Driscoll KE, Carter JM, Howard BW, Hassenbein DG, Pepelko W, Baggs RB, Oberdörster G. Pulmonary inflammatory, chemokine, and mutagenic responses in rats after subchronic inhalation of Carbon Black. Toxicol Appl Pharmacol 1995, 136:372-380.
50. Ishii H, Fujii T, Hogg JC, Hayashi S, Mukae H, Vincent R, van Eeden SF. Contribution of IL-1 beta and TNF-alpha to the initiation of the peripheral lung response to atmospheric particulates (PM10). Am J Physiol Lung Cell Mol Physiol 2004, 287:L176-L183. 10.1152/ajplung.00290.2003, 15003925.
51. Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol Suppl 1999, 57:16-21.
52. Lukacs NW, Strieter RM, Chensue SW, Widmer M, Kunkel SL. TNF-alpha mediates recruitment of polymorphonuclear neutrophils and eosinophils during airway inflammation. J Immunol 1995, 154:5411-5417.
53. Rehn B, Bruch J, Zou T, Hobusch G. Recovery of rat alveolar macrophages by bronchoalveolar lavage under normal and activated conditions. Environ Health Perspect 1992, 97:11-16. 1519522, 1396444.
54. ILSI Risk Science Institute Workshop Participants The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. Inhal Toxicol 2000, 12:1-17. ILSI Risk Science Institute Workshop Participants.
55. Oomen AG, Bos PM, Fernandes TF, Hund-Rinke K, Boraschi D, Byrne HJ, Aschberger K, Gottardo S, von der Kammer F, Kuhnel D, Hristozov D, Marcomini A, Migliore L, Scott-Fordsmand J, Wick P, Landsiedel R. Concern-driven integrated approaches to nanomaterial testing and assessment - report of the NanoSafety Cluster Working Group 10. Nanotoxicol 2014, 8:334-348.
56. Pauluhn J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol Sci 2010, 113:226-242. 10.1093/toxsci/kfp247, 19822600.
57. Bräu M, Ma-Hock L, Hesse C, Nicoleau L, Strauss V, Treumann S, Wiench K, Landsiedel R, Wohlleben W. Nanostructured calcium silicate hydrate seeds accelerate concrete hardening: a combined assessment of benefits and risks. Arch Toxicol 2012, 86:1077-1087. 10.1007/s00204-012-0839-x, 22466068.
58. Muhle H, Kittel B, Ernst H, Mohr U, Mermelstein R. Neoplastic lung lesions in rat after chronic exposure to crystalline silica. Scand J Work Environ Health 1995, 21(Suppl 2):27-29.
59. Kuempel ED, Castranova V, Geraci CL, Schulte PA. Development of risk-based nanomaterial groups for occupational exposure control. J Nanopart Res 2012, 14:1029-1043.
60. Russell WMS, Burch RL. The principles of humane experimental technique 1959, London, UK: Methuen, Reprinted by UFAW, 1992: 8 Hamilton Close, South Mimms, Potters Bar, UK.
61. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. OJ 2010, L 276:33-79. available at: http://eur-lex.europa.eu/legalcontent/EN/TXT/?qid=1396877936469&uri=CELEX:32010L0063.
62. Ma-Hock L, Gamer AO, Landsiedel R, Leibold E, Frechen T, Sens B, Linsenbuehler M, van Ravenzwaay B. Generation and characterization of test atmospheres with nanomaterials. Inhal Toxicol 2007, 19:833-848. 10.1080/08958370701479190, 17687715.
63. Yakata M, Sugita O, Sakai T, Uchiyama K, Wada K. Urinary enzyme determination and its clinical significance C. Enzyme derived from the kidney tubular epithelium-N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases. Rinsho Byori 1983, 56:90-101.
64. Kettman JR, Davies T, Chandler D, Oliver KG, Fulton RJ. Classification and properties of 64 multiplexed microsphere sets. Cytometry 1998, 33:234-243. 10.1002/(SICI)1097-0320(19981001)33:2<234::AID-CYTO19>3.0.CO;2-V, 9773885.
65. Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323. 10.1016/j.ymeth.2005.11.010, 1534009, 16481199.
66. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997, 43:1749-1756.
67. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005, 51:1854-1866. 10.1373/clinchem.2005.052241, 16081507.
68. Ruehl-Fehlert C, Kittel B, Morawietz G, Deslex P, Keenan C, Mahrt CR, Nolte T, Robinson M, Stuart BP, Deschl U. Revised guides for organ sampling and trimming in rats and mice - part 1. Exp Toxicol Pathol 2003, 55:91-106.
69. Kittel B, Ruehl-Fehlert C, Morawietz G, Klapwijk J, Elwell MR, Lenz B, O'Sullivan MG, Roth DR, Wadsworth PF. Revised guides for organ sampling and trimming in rats and mice - part 2. A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol 2004, 55:413-431. 10.1078/0940-2993-00349, 15384248.
70. Morawietz G, Ruehl-Fehlert C, Kittel B, Bube A, Keane K, Halm S, Heuser A, Hellmann J. Revised guides for organ sampling and trimming in rats and mice - part 3. A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol 2004, 55:433-449. 10.1078/0940-2993-00350, 15384249.
71. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. JASA 1955, 50:1096-1121.
72. Dunnett CW. New tables for multiple comparisons with a control. Biometrics 1964, 20:482-491.
73. Siegel S. Non-parametric statistics for the behavioural sciences 1956, New York: McGraw-Hill.